Vox Sanguinis International Forum on the use of prehospital blood products and pharmaceuticals in the treatment of patients with traumatic haemorrhage

M H Yazer, P C Spinella, S Allard, D Roxby, C So-Osman, M Lozano, K Gunn, A W-Y Shih, J Stensballe, P I Johansson, M Bagge Hansen, M Maegele, H Doughty, N Crombie, D H Jenkins, A McGinity, R M Schaefer, C Martinaud, E Shinar, R StrugoJ Chen, H Russcher

Abstract

While specific practices and transported blood products vary around the world, most of the respondents in this International Forum transported at least one blood product for the transfusion to bleeding patients en route to the hospital. The most commonly carried product was RBCs, while the use of whole blood will likely increase given the recent reports of its successful use in the civilian setting, and because of the change in the AABB's Standards regulating its use. It will be interesting to see if plasma use in the prehospital setting becomes more widely used given today's enhanced appreciated of the coagulopathy of trauma and plasma's beneficial effect in reversing it, and if blood products are transported to the scene of injury by more vehicles, that is, not just predominantly in helicopters. It was not surprising that TXA is being widely administered as close to the time of injury as possible given its potential benefit in these patients. This International Forum highlights the importance of focusing attention on prehospital transfusion management with a need to further high‐quality research in this area to guide optimal resuscitation strategies.

OriginalsprogEngelsk
TidsskriftVox Sanguinis
Vol/bind113
Udgave nummer7
Sider (fra-til)701-706
Antal sider6
ISSN0042-9007
DOI
StatusUdgivet - okt. 2018

Fingeraftryk

Dyk ned i forskningsemnerne om 'Vox Sanguinis International Forum on the use of prehospital blood products and pharmaceuticals in the treatment of patients with traumatic haemorrhage'. Sammen danner de et unikt fingeraftryk.

Citationsformater